Home / MARKSANS.NS : NSE

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does MARKSANS.NS make money? Does MARKSANS.NS have pricing power? What's the Earnings Whisper? Will MARKSANS.NS profit more as the business scales? What is MARKSANS.NS's management track record? Is MARKSANS.NS's current price justified?

Marksans Pharma Limited

₹311 +$131.13 (+72.90%)

NSE · 16 Oct 2026 09:59 UTC

Previous Close

₹307.85

Day Range

₹306₹313.5

Year Range

₹155₹350.95

Market Cap

140.93B

AVG Volume

2.98M

Trailing/Forward PE

27.26/20.39

PEG ratio

0.59

Dividend Yield

0.29%

Next Earnings Date

2026-11-05

Primary Exchange

National Stock Exchange of India

Revenue (INR) · Q

MARKSANS.NS Revenue (INR) by quarter
Period	Revenue (INR)
27 Q1	8.41B
26 Q4	8.56B
26 Q3	7.54B
26 Q2	7.2B
26 Q1	6.2B
25 Q4	7.08B
25 Q3	6.82B
25 Q2	6.42B
25 Q1	5.91B
24 Q4	5.6B

Net Income (INR) · Q

MARKSANS.NS Net Income (INR) by quarter
Period	Net Income (INR)
27 Q1	1.57B
26 Q4	1.48B
26 Q3	1.13B
26 Q2	982.5M
26 Q1	583.17M
25 Q4	905.46M
25 Q3	1.05B
25 Q2	967.16M
25 Q1	887.52M
24 Q4	782.89M

Operating Income (INR) · Q

MARKSANS.NS Operating Income (INR) by quarter
Period	Operating Income (INR)
27 Q1	1.88B
26 Q4	1.71B
26 Q3	1.36B
26 Q2	1.18B
26 Q1	770.22M
25 Q4	2.86B
25 Q3	1.18B
25 Q2	1.16B
25 Q1	1.08B
24 Q4	885.87M

EBITDA · Q

Cash Flows · Q

EPS · Q

Expenses · Q

Cash & Debt · Q

Debt ratios · Q

Margins · Q

Return on Capital · Q

Shares Outstanding · Q

Dividends (INR) · Q

Employee Count

Book Value Per Share · Q

Total Assets · Q

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

Marksans Pharma Limited

Video analysis: MARKSANS.NS

News: MARKSANS.NS

Similar companies